SCHEMBL6202744

SCHEMBL6202744

O=C1NCCn2c(-c3cccc(CO)c3)nc3cccc1c32

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
PARP1 P09874 20/20 1.00

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6197512 0.89 PARP1 (1.00) PARP1
SCHEMBL7163111 0.88 PARP1 (0.79) PARP1
SCHEMBL5074040 0.86 PARP1 (0.76) PARP1
SCHEMBL7161746 0.86 PARP1 (1.00) PARP1
SCHEMBL6201192 0.86 PARP1 (0.76) PARP1
SCHEMBL7554564 0.85 PARP1 (0.80) PARP1
SCHEMBL831830 0.84 PARP1 (1.00) PARP1
SCHEMBL12750631 0.83 PARP1 (0.76) PARP1
SCHEMBL7553824 0.83 PARP1 (0.79) PARP1
SCHEMBL7552024 0.83 PARP1 (0.76) PARP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1208104-B1 TRICYCLIC INHIBITORS OF POLY(ADP-RIBOSE) POLYMERASES AGOURON PHARMA (US) 2005-01-19 EP disclosed
US-6548494-B1 3,4-dihydro-2H-(1,4)diazepino(6,7,1-hi)indol-1-one or 1-thione derivatives where indole C3 could also be N; use treating cancers as well as stroke, head trauma, and neurodegenerative diseases AGOURON PHARMACEUTICALS, INC. 2003-04-15 US disclosed